MECP2 and pulmonary fibrosis: Notably, knockdown of Mecp2 expression in the lung via intratracheal injection of liposomes carrying Mecp2 siRNA reversed established BLM‐induced lung fibrosis and decreased the infiltration of M2 macrophages in the lung without any side‐effects (Figure 8).